1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites

Did Germany's CureVac COVID vaccine ultimately fail?

04:14

This browser does not support the video element.

June 17, 2021

Germany's CureVac was supposed to be a big player in COVID vaccinations. With an efficacy rate of just 47%, the much-hyped vaccine underperformed. The EU had already ordered 400 million doses.

Skip next section DW's Top Story

DW's Top Story

Skip next section More stories from DW

More stories from DW